EUVIMEDEUVIMED entdecken
Crossref

TERAPIAS BASEADAS EM PEPTÍDEOS NA MEDICINA MODERNA: APLICAÇÕES CLÍNICAS E DESAFIOS NA ESTABILIDADE E BIODISPONIBILIDADE – REVISÃO SISTEMÁTICA

Bruno Sander

Revista Científica Ipedss · 2026 · 06 (03)

DOI: 10.55703/27644006060301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Científica Ipedss, 2026. Verfasst von Bruno Sander.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peptide-based therapies exhibit high pharmacological selectivity and a broad ability to modulate receptors, enzymes, and signaling pathways; however, their clinical development is limited by enzymatic degradation, poor membrane permeability, rapid clearance, and low bioavailability. This study aimed to analyze contemporary clinical applications of therapeutic peptides and evaluate the strategies used to improve their molecular stability, half-life, absorption, and tissue distribution. A systematic review was conducted according to the PRISMA 2020 recommendations. The primary search was performed in PubMed/MEDLINE from database inception to July 20, 2026, with complementary verification in PubMed Central, Crossref, and official journal records. Original clinical, pharmacokinetic, translational, and preclinical studies involving peptides developed for therapeutic purposes were eligible. A total of 50 studies published between 2001 and 2025 were included and organized into five thematic domains. Amino acid substitutions, lipidation, albumin binding, conformational restriction, PEGylation, depot formulations, implants, and absorption enhancers increased peptide stability and prolonged pharmacological exposure. Semaglutide, tirzepatide, and other incretin-based agonists produced substantial improvements in glycemic control, body weight reduction, and cardiovascular outcomes. Relevant clinical applications were also identified in genetic forms of obesity, achondroplasia, short bowel syndrome, osteoporosis, neuroendocrine tumors, drug-resistant HIV infection, hereditary angioedema, pruritus, refractory pain, and erythropoietic protoporphyria. Nevertheless, oral absorption remained variable and dependent on dosing conditions, whereas ingestible devices and other delivery technologies were supported predominantly by preclinical evidence. Negative findings involving cilengitide and NLY01 demonstrated that prolonged half-life and biological plausibility do not ensure clinical efficacy when tissue distribution or target engagement is insufficient. Peptide-based therapies therefore represent a versatile therapeutic platform whose success depends on the integration of molecular engineering, stability, bioavailability, tissue targeting, safety, and clinical applicability. Keywords: peptides; biological availability; drug stability; drug delivery systems.

Zitieren

APA

Sander, B. (2026). TERAPIAS BASEADAS EM PEPTÍDEOS NA MEDICINA MODERNA: APLICAÇÕES CLÍNICAS E DESAFIOS NA ESTABILIDADE E BIODISPONIBILIDADE – REVISÃO SISTEMÁTICA. Revista Científica Ipedss, 06(03). https://doi.org/10.55703/27644006060301

Vancouver

Sander B. TERAPIAS BASEADAS EM PEPTÍDEOS NA MEDICINA MODERNA: APLICAÇÕES CLÍNICAS E DESAFIOS NA ESTABILIDADE E BIODISPONIBILIDADE – REVISÃO SISTEMÁTICA. Revista Científica Ipedss. 2026;06(03). doi:10.55703/27644006060301

BibTeX
@article{Sander2026,
  author = {Sander, Bruno},
  title = {TERAPIAS BASEADAS EM PEPTÍDEOS NA MEDICINA MODERNA: APLICAÇÕES CLÍNICAS E DESAFIOS NA ESTABILIDADE E BIODISPONIBILIDADE – REVISÃO SISTEMÁTICA},
  journal = {Revista Científica Ipedss},
  year = {2026},
  volume = {06},
  number = {03},
  doi = {10.55703/27644006060301}
}
Kostenlos starten →